Moreover, we found in the current work a significant reduction in TH density and myocardial NE contents by either SGLT2i or GLP1, suggesting attenuation of the sympathetic nerve fiber activity is another possible mechanism for the cardioprotective effects of these new antidiabetic agents in DCM. The gene discussed is GCG; the disease is familial dilated cardiomyopathy.